The tentative agenda for BioTaiwan 2017 was recently announced, Now is its 16th year, BioTaiwan 2017 is 5 events in 1, including the BioBusiness Asia Conference, Greater China & Asia-Pacific Opportunities Conference, BioTaiwan Exhibition, Company Presentations, One-on-one Partnering and a full Seminar and Workshop program. It’s only a click away to discover the opportunities that await in biotech investment, collaboration, innovation, and services.
Taiwan is undergoing a boom in biotechnology, rewarding years of dedicated effort from its stakeholders. More and more locally-developed drugs are entering late-stage clinical trials, and new companies, service providers, and manufacturing facilities are emerging to fill rapidly growing industry needs. Overseas interest is picking up as well, with licensing, partnering and investment agreements at an all-time high. The total market capitalization of local publicly-listed biotech companies has soared, increasing 700 percent since 2008’s capital market crash, rewarding stakeholders for their patience and support.
The biotech industry in Taiwan has a set of unique characteristics and strengths that make it an appealing prospect to the global life science community looking for a partnership, investment or licensing opportunities. These include:
As healthcare is moving from a “one size fits all” model towards a more personalized approach, bringing together Taiwan’s newest diagnostic tools with precision therapeutics, existing strengths in ICT and device industries means that Taiwan is well placed to excel in this evolving healthcare ecosystem.
Save the dates and join to experience the vibrancy, innovation, and inspiration of Taiwan’s biotech industry and explore the tremendous opportunities on offer at BioTaiwan 2017!
Why Attend BioTaiwan 2017?
＊ Network with top executives, investors, experts and renown leaders from Taiwan, China, and beyond
＊ Exhibit bio-clusters, technologies, unique products, and services
＊ Discover biopharma innovations in Taiwan and Asia
＊ Capture Greater China and Asia’s biotech market opportunities through Taiwan
＊ Explore R&D, products, services and new partnerships
Taiwan’s biotech industry market value has reached 900bil TWD (30bil USD) and will soon approach its first trillion TWD as Taiwan becomes an integral part of the global biopharma industry chain. The government’s initiatives to support Taiwan’s biotech development and innovation are critical for continued strong growth momentum.
BioBuisness Asia explores such investment opportunities in Taiwan. The event takes an in-depth look at issues regarding bio-investing and future trends in biomedical and life sciences within the Asia region. In 2016, the BioTaiwan exhibition had a record number of participants, reaching a total of 605 exhibitors, 1,305 booths, and 100,786 plus visitors representing Taiwan, Japan, Korea, China, India, North America and countries from the European Union.
Click here to register for BioTaiwan 2017 https://bio-taiwan.com/en/registration/plan
Date: June 28 (Wed.) – July 2 (Sun.)
Venue: TWTC Nangang Exhibition Hall (No. 1, Jingmao 2nd. Rd., Nangang Dist., Taipei City)
For BioTaiwan 2017 Conferences
Wendy Hung firstname.lastname@example.org +886-2-2655-8692 ext. 13
For BioTaiwan 2017 Exhibition
Are you working on a disruptive solution built around unique, protected or hard-to-reproduce technological or…
National Cheng Kung University (NCKU) President Huey-Jen Jenny Su was invited by Taipei First Girls High School (TFG)…
The fight against environmental pollution could soon witness a paradigm shift, with a new study showing that domestic…
Internet is huge! Help us find great content
Never miss a thing! Sign up for our newsletter to stay updated.
Research Stash is a curated collection of tools and News for S.T.E.M researchers